TW200722432A - Thiazole compounds - Google Patents

Thiazole compounds

Info

Publication number
TW200722432A
TW200722432A TW095110187A TW95110187A TW200722432A TW 200722432 A TW200722432 A TW 200722432A TW 095110187 A TW095110187 A TW 095110187A TW 95110187 A TW95110187 A TW 95110187A TW 200722432 A TW200722432 A TW 200722432A
Authority
TW
Taiwan
Prior art keywords
hydrogen atom
optionally substituted
group
thiazole compounds
cf2p
Prior art date
Application number
TW095110187A
Other languages
Chinese (zh)
Inventor
Tomoharu Tsukada
Toshiyasu Takemoto
Takahide Nishi
Takahiro Yamane
Osamu Kanno
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of TW200722432A publication Critical patent/TW200722432A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6536—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and sulfur atoms with or without oxygen atoms, as the only ring hetero atoms
    • C07F9/6539—Five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The subject of the present invention is to find out a prophylactic and/or therapeutic medicine for the diabetes etc. having an excellent actively and security. A compound of the following fomula (I), [wherein, each of the R1X and R1Y differently represents a hydrogen atom, a halogen atom, a C1-C6 alkyl group, P(O)(OH)2, OP(O)(OH)2, CH2P(O)(OH)2, CF2P(O)(OH)2, OCH2P(O)(OH)2, each of the R2 and R3 independently represents a hydrogen atom, an optionally substituted C1-C6 aliphatic acyl group, etc., R4 represents a hydrogen atom, an amino group, etc., X represents an optionally substituted C1-C3 alkylene group], or the pharmaceutically acceptable salt thereof is provided.
TW095110187A 2005-03-25 2006-03-24 Thiazole compounds TW200722432A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2005089010 2005-03-25

Publications (1)

Publication Number Publication Date
TW200722432A true TW200722432A (en) 2007-06-16

Family

ID=37053287

Family Applications (1)

Application Number Title Priority Date Filing Date
TW095110187A TW200722432A (en) 2005-03-25 2006-03-24 Thiazole compounds

Country Status (2)

Country Link
TW (1) TW200722432A (en)
WO (1) WO2006104030A1 (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20090047458A (en) 2006-08-08 2009-05-12 사노피-아벤티스 Arylaminoaryl-alkyl-substituted imidazolidine-2,4-diones, processes for preparing them, medicaments comprising these compounds, and their use
EP2025674A1 (en) 2007-08-15 2009-02-18 sanofi-aventis Substituted tetra hydro naphthalines, method for their manufacture and their use as drugs
EP2058308A1 (en) 2007-11-12 2009-05-13 Merck Sante Benzimidazoledihydrothiadiazinone derivatives used as fructose-1,6-biphosphatase inhibitors and pharmaceutical compositions containing same.
US8470841B2 (en) 2008-07-09 2013-06-25 Sanofi Heterocyclic compounds, processes for their preparation, medicaments comprising these compounds, and the use thereof
WO2010068601A1 (en) 2008-12-08 2010-06-17 Sanofi-Aventis A crystalline heteroaromatic fluoroglycoside hydrate, processes for making, methods of use and pharmaceutical compositions thereof
RU2012111354A (en) 2009-08-26 2013-10-10 Санофи NEW CRYSTALLINE HYDRATES OF FLUORGYCLOSIDES CONTAINING THEIR PHARMACEUTICAL DRUGS AND THEIR USE
WO2011107494A1 (en) 2010-03-03 2011-09-09 Sanofi Novel aromatic glycoside derivatives, medicaments containing said compounds, and the use thereof
EP2582709B1 (en) 2010-06-18 2018-01-24 Sanofi Azolopyridin-3-one derivatives as inhibitors of lipases and phospholipases
US8530413B2 (en) 2010-06-21 2013-09-10 Sanofi Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments
TW201221505A (en) 2010-07-05 2012-06-01 Sanofi Sa Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament
TW201215388A (en) 2010-07-05 2012-04-16 Sanofi Sa (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments
TW201215387A (en) 2010-07-05 2012-04-16 Sanofi Aventis Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament
WO2012120054A1 (en) 2011-03-08 2012-09-13 Sanofi Di- and tri-substituted oxathiazine derivates, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
EP2683699B1 (en) 2011-03-08 2015-06-24 Sanofi Di- and tri-substituted oxathiazine derivates, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
WO2012120056A1 (en) 2011-03-08 2012-09-13 Sanofi Tetrasubstituted oxathiazine derivatives, method for producing them, their use as medicine and drug containing said derivatives and the use thereof
US8901114B2 (en) 2011-03-08 2014-12-02 Sanofi Oxathiazine derivatives substituted with carbocycles or heterocycles, method for producing same, drugs containing said compounds, and use thereof
US8828995B2 (en) 2011-03-08 2014-09-09 Sanofi Branched oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
WO2013037390A1 (en) 2011-09-12 2013-03-21 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
WO2013045413A1 (en) 2011-09-27 2013-04-04 Sanofi 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW260664B (en) * 1993-02-15 1995-10-21 Otsuka Pharma Factory Inc
AU773892B2 (en) * 1999-06-30 2004-06-10 H. Lundbeck A/S Selective NPY (Y5) antagonists
JP2004018489A (en) * 2002-06-19 2004-01-22 Otsuka Pharmaceut Factory Inc Acat-1 inhibitor

Also Published As

Publication number Publication date
WO2006104030A1 (en) 2006-10-05

Similar Documents

Publication Publication Date Title
TW200722432A (en) Thiazole compounds
TW200745034A (en) New compounds
TW200637869A (en) The spiroketal derivatives and the use as therapeutical agent for diabetes of the same
TW200642683A (en) Heterocyclic compound
TW200726470A (en) 6,7-unsaturated-7-carbamoylmorphinan derivatives
WO2008114819A1 (en) Novel adenine compound
TN2011000422A1 (en) Benzofuran derivatives
MX2009003927A (en) Thioglucose spiroketal derivative and use thereof as therapeutic agent for diabetes.
MY144960A (en) Morpholine type cinnamide compound
MX2009012283A (en) Nitrogen-containing heterocyclic derivative having 11 î²-hydroxysteroid dehydrogenase type i inhibitory activity.
TW200420542A (en) A compound having TGF β inhibition activity and a medicinal composition containing the same
NO20052074L (en) Substituted benzoxazinones and uses thereof.
MX2009004764A (en) 5-hydroxymethyl-oxazolidin-2-one derivatives.
WO2008108380A3 (en) Pyrrole compounds
WO2005012269A8 (en) Novel azole compound
IN2014CN00613A (en)
MX2008013728A (en) Neurogenesis inducer or neuropathy therapeutic agent comprising alkyl ether derivative or salt thereof.
WO2007122634A3 (en) Pyrimidinediones as tyrosine kinase inhibitors
WO2006088720A3 (en) 9-substituted tetracyclines
TW200716527A (en) Substituted aminoalkyl-and amidoalkyl-benzopyran derivatives
TW200612931A (en) Substituted biphenyl derivatives
RS97004A (en) Benzoxazine derivatives as 5-ht6 modulators and uses thereof
MX2010010471A (en) Novel tetrahydroisoquinoline derivative.
MY138466A (en) Aminoalkoxyndoles as 5-ht6-receptor ligands for the treatment of cns-disorders
TW200720265A (en) Agent for treatment of hematopoietic tumor